Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Diabetes Mellitus, Type 1
Interventions: Bone density and carotid ultrasound; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 45 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Endometriosis
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 40 Years to 50 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer (Triple Negative Breast Cancer (TNBC)), Renal Cell Carcinoma (Kidney Cancer), Melanoma (Skin Cancer), Non-Small Cell Lung Cancer, MSI-H/dMMR Rectal Cancer, Squamous Cell Carcinoma Mouth, Invasive Mammary Carcinoma, Classic Hodgkin Lymphoma
Interventions: Dual-Energy X-ray Absorptiometry (DXA), High Resolution peripheral Quantitative Computed Tomography (HRpQCT); Device
Lead sponsor: Jessica Mezzanotte Sharpe; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sickle Cell Disease, Sickle Cell Anemia, Low Bone Density, Osteoporosis, Osteopenia, Vertebral Fracture, Vertebral Compression, Osteonecrosis, Ischemic Necrosis, Avascular Necrosis
Interventions: Dual-energy X-ray absorptiometry, Vertebral fracture analysis, Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Obesity, Morbid, Gastric Bypass
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 25 Years to 70 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Bone Mineral Density, Hemophilia A, Hemophilia B
Interventions: DXA scan + MRI; Other
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 25 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Primary Hyperparathyroidism, Bone Diseases, Metabolic, Osteoporosis, Postmenopausal, Bone Loss, Postmenopausal
Interventions: Forearm exercise program, Walking program; Other
Lead sponsor: Columbia University; Other
Eligibility: 45 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoporosis
Interventions: Ronacaleret, Teriparatide, Alendronate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 9
States / cities: Oakland, California • Palm Desert, California • Walnut Creek, California + 6 more

Conditions: Bone Mineralization, Adolescent Development
Interventions: Beverage containing calcium citrate malate, Beverage fortified with calcium citrate malate; Dietary Supplement
Lead sponsor: Purdue University; Other
Eligibility: 11 Years to 15 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Osteoporosis
Interventions: magnesium; Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 55 Years to 75 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Contraception, Bone Density
Interventions: Depo-Provera Contraceptive Injection - DP150CI; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2007
U.S. locations: 12
States / cities: Los Angeles, California • Palo Alto, California • Torrance, California + 9 more

Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Vitamin D Deficiency
Interventions: Vitamin D and Calcium Citrate; Dietary Supplement
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 10 Years to 29 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Primary Hyperparathyroidism
Interventions: Denosumab, Placebo; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteogenesis Imperfecta
Interventions: Teriparatide (FORTEO), Placebos; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 3
States / cities: Baltimore, Maryland • Portland, Oregon • Houston, Texas

Conditions: Osteoporosis
Interventions: Lagenbone; Dietary Supplement
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 40 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Whittier, California

Conditions: Iron Deficiency, Iron Deficiency Anemia (IDA), Vitamin D Deficiency, Vitamin D Insufficiency, Low Energy Availability, Bone Density
Interventions: Iron and Vitamin D Deficiencies Correction; Dietary Supplement
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Steroid-induced Osteopor, Glucocorticoid-induced Ostepor
Interventions: Denosumab, Placebo for risendronate, Risendronate, Placebo for denosumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 18
States / cities: Birmingham, Alabama • Sacramento, California • Lakewood, Colorado + 14 more

Conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
Interventions: Teriparatide, Vibration; Drug · Device
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Vitamin D Deficiency
Interventions: Vitamin D 10000 UNT, Vitamin D 5000 UNT; Drug
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Anorexia Nervosa
Interventions: Physiologic Estrogen/progesterone, Placebo; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Marfan Syndrome
Interventions: Exercise; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 19 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Left Ventricular Dysfunction
Interventions: Adult stem cells, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 5
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 2 more

Conditions: Multiple Sclerosis, Low Bone Density
Interventions: Copaxone, Interferon-beta 1a, Interferon-beta 1b; Drug
Lead sponsor: Nancy Hammond, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Kansas City, Kansas

Conditions: Osteoporosis
Interventions: CT; Diagnostic Test
Lead sponsor: St. Louis Joint Replacement Institute; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Bridgeton, Missouri

Search by objective public record fields.

Bone and Vascular Health in Postmenopausal Women With Type 1 Diabetes

Effects of Endometriosis on Bone Mineral Density

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

Sickle Cell Disease (SCD) Bone Pain Study

Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton

Osteoporosis and MRI Study in Hemophilia

Radius Loading in Primary Hyperparathyroidism

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Calcium Metabolism in Asian Adolescents

Magnesium Supplementation to Prevent Bone Loss

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Nutrition and Body Composition in Acute Lymphoblastic Leukemia

Denosumab in Primary Hyperparathyroidism

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

Effects of Lagenbone on Bone Mineral Density

Collegiate Athlete Study

Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

Effects of Vitamin D Supplementation on Strength, Bone Density, and Injury Risk in Collegiate Athletes

Effects of Anorexia Nervosa on Bone Mass in Adolescents

Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond

Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

S-32 PG 242 Short Stem